Cargando…
Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters
Cancer is the second cause of death worldwide, surpassed only by cardiovascular diseases, due to the lack of early diagnosis, and high relapse rate after conventional therapies. Chemotherapy inhibits the rapid growth of cancer cells, but it also affects normal cells with fast proliferation rate. The...
Autores principales: | Montaño-Samaniego, Mariela, Bravo-Estupiñan, Diana M., Méndez-Guerrero, Oscar, Alarcón-Hernández, Ernesto, Ibáñez-Hernández, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768042/ https://www.ncbi.nlm.nih.gov/pubmed/33381459 http://dx.doi.org/10.3389/fonc.2020.605380 |
Ejemplares similares
-
Targeted Expression to Liver of an antimiR-33 Sponge as a Gene Therapy Strategy against Hypercholesterolemia: In Vitro Study
por: Montaño-Samaniego, Mariela, et al.
Publicado: (2023) -
Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models
por: Canals Hernaez, Diana, et al.
Publicado: (2022) -
Strategies to target the cancer driver MYC in tumor cells
por: Weber, Leonie I., et al.
Publicado: (2023) -
Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors
por: Cai, Ming, et al.
Publicado: (2022) -
Targeting collagen in tumor extracellular matrix as a novel targeted strategy in cancer immunotherapy
por: Liu, Jiayang, et al.
Publicado: (2023)